Dr. Olusola A. Ajilore, MD

Dr. Ajilore practices at University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System.

Dr. Ajilore's NPI, 1740213347, was assigned on July 8, 2006. Dr. Ajilore graduated from Stanford University School Of Medicine in 2001. Dr. Ajilore holds Illinois license 036123820.

Dr. Ajilore's primary practice is University of Illinois Hospital, at 1740 West Taylor St Suite 1400, Chicago, IL 60612 in Cook County. The practice phone is (312) 996-3900.

Dr. Ajilore's primary practice is University of Illinois Hospital in Chicago, Illinois, part of University of Illinois System. The medical group on file is University of Illinois Physicians Group (UIPG). Dmand AI also links Dr. Ajilore to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ajilore practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Ajilore's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Ajilore is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Ajilore's licenses on file in 2 states: Illinois and California.

Dmand AI lists anxiety, bipolar disorder and depression among the conditions Dr. Ajilore treats.

CMS data shows 70 Medicare services from Dr. Ajilore across 2 procedure codes in 2021, for 21 Medicare patients. Medicare paid $3,390 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 21 Medicare patients who saw Dr. Ajilore in 2024. 75% of them have anxiety, and 75% have high cholesterol. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ajilore's median patient age at 39, with 17% women.

In 2024, Dr. Ajilore wrote 342 Medicare Part D claims for 31 patients. 97% of them were for generic drugs. CMS names the drug for 228 of them, across 10 drugs with 11 or more claims each, at $6,247 in total drug cost. In 2023, CMS named 269 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Ajilore for performance year 2024, reported as part of a group. Dr. Ajilore accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ajilore as offering telehealth.

Dmand AI links 151 papers to Dr. Ajilore, published from 2013 to 2025. 2023 was the busiest year, with 21. The most frequent topics are Brain, Magnetic Resonance Imaging and Depression. Dr. Ajilore has published most often in Am J Geriatr Psychiatry. Dr. Ajilore's most frequent co-authors are Anand N. Kumar, Jun Ma, MD and John Paul Zulueta, MD.

Dmand AI links Dr. Ajilore to 4 clinical trials. 2 are still active or recruiting. Conditions studied include Cognitive Dysfunction, Cyclothymic Disorder and Depression. University of Illinois at Chicago sponsors the most, 4.

CMS Open Payments shows 11 general payments to Dr. Ajilore from 5 drug and device companies from 2022 to 2023. Travel and lodging make up the largest share, 56% of the total. Boehringer Ingelheim USA, Inc. paid the most, $11,745.

Dr. Ajilore graduated from Stanford University School Of Medicine in 2001.

Dr. Ajilore is in network with 5 carriers, including Aetna, Cigna and HCSC. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.